These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Seminar: discussion on the chemotherapy of pulmonary tuberculosis and related problems (author's transl)]. Shen ZL Zhonghua Nei Ke Za Zhi; 1980 Nov; 19(6):472-5. PubMed ID: 7297271 [No Abstract] [Full Text] [Related]
6. [Symposium: problem of retreated pulmonary tuberculosis (author's transl)]. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):237-40. PubMed ID: 555435 [No Abstract] [Full Text] [Related]
7. [Microbiological methods in selection of optimal drug combinations in complex treatment of destructive pulmonary tuberculosis]. Dolzhanskiĭ VM; Sagalovich VIa; Girin DV; Kaplov LP Probl Tuberk; 1978 Sep; (9):64-9. PubMed ID: 704601 [No Abstract] [Full Text] [Related]
8. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)]. Kekkaku; 1978 Sep; 53(9):471-6. PubMed ID: 713226 [No Abstract] [Full Text] [Related]
9. [Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl]. Zorić M; Jarebica M; Teofanović D; Toula Z; Milicević N Plucne Bolesti Tuberk; 1977; 29(3-4):207-17. PubMed ID: 609627 [No Abstract] [Full Text] [Related]
10. [Clinical trials on chemotherapy of tuberculosis in Chile (author's transl)]. Farga V Rev Med Chil; 1981 Aug; 109(8):769-73. PubMed ID: 7043693 [No Abstract] [Full Text] [Related]
11. [A case of tuberculosis with a transient aggravation during initial phase of chemotherapy (author's transl)]. Kishimoto H; Kawachi H; Shimokata K Kekkaku; 1982 Feb; 57(2):95-8. PubMed ID: 7069978 [No Abstract] [Full Text] [Related]
12. [Effect of intravenous therapy on blood circulation in patients with pulmonary tuberculosis in the preoperative period]. Bryskovskiĭ NK Probl Tuberk; 1976; 3():35-8. PubMed ID: 967853 [No Abstract] [Full Text] [Related]
13. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis]. Pletnev GV; Krasnov DV Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961 [No Abstract] [Full Text] [Related]
14. [Side-effects of antituberculous drugs observed in five different regimens (author's transl)]. Aizawa H; Sakai K; Kishida K Kekkaku; 1977 May; 52(5):229-34. PubMed ID: 886680 [No Abstract] [Full Text] [Related]
15. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)]. Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917 [No Abstract] [Full Text] [Related]
19. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods]. Smirnov GA; Valiev RSh Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207 [TBL] [Abstract][Full Text] [Related]
20. [Compliance of tuberculous patients in a chest hospital (author's transl)]. Nagy P; Urbanczik R Prax Klin Pneumol; 1982 Feb; 36(2):89-92. PubMed ID: 7100102 [No Abstract] [Full Text] [Related] [Next] [New Search]